Portfolio company
Corus Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops biopharmaceutical medicines to treat patients with HIV, viral hepatitis, cancer and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmasset
This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Chimerix
This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.
ViiV Healthcare
This company develops and provides pharmaceutical medicines for the treatment and prevention of HIV for patients and healthcare professionals.
Panacos
This biotechnology company develops small molecule antiviral drugs to treat patients with human immunodeficiency virus and other serious infectious diseases.
Antios Therapeutics
This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.
Vir
This clinical-stage biopharmaceutical company develops medicines for serious infectious diseases and cancer for global patients.
Arcus Biosciences
This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.
